Cargando…

NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation

The histone methyltransferase NSD2/WHSC1/MMSET is overexpressed in a number of solid tumors but its contribution to the biology of these tumors is not well understood. Here, we describe that NSD2 contributes to the proliferation of a subset of lung cancer cell lines by supporting oncogenic RAS trans...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Carpizo, Verónica, Sarmentero, Jacinto, Han, Bomie, Graña, Osvaldo, Ruiz-Llorente, Sergio, Pisano, David G., Serrano, Manuel, Brooks, Harold B., Campbell, Robert M., Barrero, Maria J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015087/ https://www.ncbi.nlm.nih.gov/pubmed/27604143 http://dx.doi.org/10.1038/srep32952

Ejemplares similares

CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation
por: Garcia-Carpizo, Veronica, et al.
Publicado: (2018)

The Role of Methyltransferase NSD2 as a Potential Oncogene in Human Solid Tumors
por: Chen, Rui, et al.
Publicado: (2020)

Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer
por: Zhao, Li-hao, et al.
Publicado: (2021)

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia
por: Mohanty, Sagarajit, et al.
Publicado: (2020)

In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L
por: Morishita, Masayo, et al.
Publicado: (2014)

An Activating Mutation of the NSD2 Histone Methyltransferase Drives Oncogenic Reprogramming in Acute Lymphocytic Leukemia
por: Swaroop, Alok, et al.
Publicado: (2018)

Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis
por: Gameiro, Steven F., et al.
Publicado: (2021)

NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis
por: Peri, Suraj, et al.
Publicado: (2017)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Structural basis of the regulation of the normal and oncogenic methylation of nucleosomal histone H3 Lys36 by NSD2
por: Sato, Ko, et al.
Publicado: (2021)

Hair follicle regeneration suppresses Ras-driven oncogenic growth
por: Pineda, Cristiana M., et al.
Publicado: (2019)

NSD1 in erythroid differentiation and leukemogenesis
por: Tauchmann, Samantha, et al.
Publicado: (2020)

Transforming ras oncogenes and multistage carcinogenesis.
por: Balmain, A.
Publicado: (1985)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

H3K36me2 methyltransferase NSD2 orchestrates epigenetic reprogramming during spermatogenesis
por: Li, Zhiming, et al.
Publicado: (2022)

NSD3 keeps IRF3 active
por: Mino, Takashi, et al.
Publicado: (2017)

Covalent inhibition of NSD1 histone methyltransferase
por: Huang, Huang, et al.
Publicado: (2020)

Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
por: Augsten, Martin, et al.
Publicado: (2014)

The PWWP domain of the human oncogene WHSC1L1/NSD3 induces a metabolic shift toward fermentation
por: Rona, Germana B., et al.
Publicado: (2016)

BTB-Zinc Finger Oncogenes Are Required for Ras and Notch-Driven Tumorigenesis in Drosophila
por: Doggett, Karen, et al.
Publicado: (2015)

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
por: Catalano, Antonella, et al.
Publicado: (2021)

The role of RAS oncogenes in controlling epithelial mechanics
por: Nyga, Agata, et al.
Publicado: (2023)

The role of histone lysine methyltransferase NSD3 in cancer
por: Han, Xu, et al.
Publicado: (2018)

NSD2 as a Promising Target in Hematological Disorders
por: Azagra, Alba, et al.
Publicado: (2022)

P1347: H3K36 HISTONE METHYLTRANSFERASE NSD3 FUNCTIONS AS A CRUCIAL EPIGENETIC REGULATOR OF ERYTHROPOIESIS
por: Shah, Arunim, et al.
Publicado: (2023)

Sos-mediated cross activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis
por: Jeng, Hao-Hsuan, et al.
Publicado: (2012)

Oncogenic epigenetic control
por: Stein, Gary S., et al.
Publicado: (2016)

Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth
por: Shin, Seung-Min, et al.
Publicado: (2020)

IV International Conference on Nuclear Structure and Dynamics (NSD2019)
por: de Angelis, G., et al.
Publicado: (2019)

Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma
por: He, Chao, et al.
Publicado: (2019)

Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase
por: Rathert, Philipp
Publicado: (2021)

Cerebrovascular diseases in two patients with entire NSD1 deletion
por: Itai, Toshiyuki, et al.
Publicado: (2021)

Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
por: Krossa, Imène, et al.
Publicado: (2022)

Ras oncogene mutations and survival in patients with lung cancer
por: Ferretti, G, et al.
Publicado: (2006)

Intercellular Transfer of Oncogenic H-Ras at the Immunological Synapse
por: Rechavi, Oded, et al.
Publicado: (2007)

Acute sensitivity of the oral mucosa to oncogenic K-ras
por: van der Weyden, Louise, et al.
Publicado: (2011)

Ras Downstream Effector GGCT Alleviates Oncogenic Stress
por: He, Zaoke, et al.
Publicado: (2019)

Structure, signaling and the drug discovery of the Ras oncogene protein
por: Han, Chang Woo, et al.
Publicado: (2017)

Editorial: Oncogenic RAS-Dependent Reprogramming of Cellular Plasticity
por: Konstantinidou, Georgia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dkfmh850hl4lgfroqe6q8cse6m